These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6194244)

  • 1. Lysis of inducer T cell clones by activated macrophages and macrophage-like cell lines.
    Rao A; Faas SJ; Miller LJ; Riback PS; Cantor H
    J Exp Med; 1983 Oct; 158(4):1243-58. PubMed ID: 6194244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
    Stout RD; Bottomly K
    J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
    Kelso A; Glasebrook AL
    J Immunol; 1984 Jun; 132(6):2924-31. PubMed ID: 6202766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
    Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
    J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
    MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
    Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
    J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of macrophage activating factor by cytolytic and noncytolytic T lymphocyte clones.
    Kelso A; Glasebrook AL; Brunner KT; Kanagawa O; Engers HD; MacDonald HR; Cerottini JC
    Adv Exp Med Biol; 1982; 155():493-8. PubMed ID: 6760696
    [No Abstract]   [Full Text] [Related]  

  • 9. Different antigen-presenting cells differ in their capacity to induce lymphokine production and proliferation of an apo-cytochrome c-specific T cell clone.
    Baumhüter S; Bron C; Corradin G
    J Immunol; 1985 Aug; 135(2):989-94. PubMed ID: 2409165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization.
    Sheppard HW; Scott PA; Dwyer DM
    J Immunol; 1983 Sep; 131(3):1496-503. PubMed ID: 6193191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis in vitro and in vivo of Mycobacterium bovis strain BCG-specific T cell clones.
    Pedrazzini T; Louis JA
    J Immunol; 1986 Mar; 136(5):1828-34. PubMed ID: 2419415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
    Biondi A; Roach JA; Schlossman SF; Todd RF
    J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation requirements of cloned inducer T cells. II. The failure of some clones to respond to antigen presented by activated B cells.
    Dekruyff RH; Cantor H; Dorf ME
    J Immunol; 1986 Jan; 136(2):446-51. PubMed ID: 3484492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones.
    Kelso A; Munck A
    J Immunol; 1984 Aug; 133(2):784-91. PubMed ID: 6203981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.
    Sia DY; Lachmann PJ; Leung KN
    Immunology; 1984 Apr; 51(4):755-63. PubMed ID: 6200428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of macrophages by lymphokines from T-cell clones: evidence for different macrophage-activating factors.
    Gemsa D; Kubelka C; Debatin KM; Krammer PH
    Mol Immunol; 1984 Dec; 21(12):1267-76. PubMed ID: 6395005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous T-cell lymphokine production and enhanced macrophage Ia expression and tumoricidal activity in MRL-lpr mice.
    Lu CY; Unanue ER
    Clin Immunol Immunopathol; 1982 Nov; 25(2):213-22. PubMed ID: 6762274
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity.
    Weiss J; Schwinzer B; Kirchner H; Gemsa D; Resch K
    Immunobiology; 1986 Apr; 171(3):234-51. PubMed ID: 3086216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific T helper clones in a nonresponder strain require augmentation for expression of helper activity. Evidence for a possible antigen presentation defect in B cells.
    Shastri N; Kawahara DJ; Miller A; Sercarz EE
    J Immunol; 1984 Sep; 133(3):1215-21. PubMed ID: 6205071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.